111 related articles for article (PubMed ID: 6221545)
21. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
Peskar BA; Förstermann U; Simmet T
Artery; 1980; 8(1):1-6. PubMed ID: 7000038
[TBL] [Abstract][Full Text] [Related]
22. U-46619, a selective thromboxane A2-like agonist? [proceedings].
Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
Br J Pharmacol; 1980 Jan; 68(1):127P-128P. PubMed ID: 7357146
[No Abstract] [Full Text] [Related]
23. ONO-3708: an effective thromboxane A2 antagonist possessing 3-acylaminopinane skeleton.
Suga H; Hamanaka N; Kondo K; Miyake H; Ohuchida S; Arai Y; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():799-802. PubMed ID: 2960194
[No Abstract] [Full Text] [Related]
24. Tetrahydrocarbazol-1-acetic acids: new class of thromboxane receptor antagonists.
Girard Y; Yoakim-Rancourt C; Hamel P; Gillard JW; Guindon Y; Letts G; Evans J; Léveillé C; Ethier D; Lord A
Prog Clin Biol Res; 1989; 301():585-9. PubMed ID: 2529558
[No Abstract] [Full Text] [Related]
25. Significance of prostaglandins and thromboxane A2 for the mode of action of cardiovascular drugs.
Förster W
Adv Prostaglandin Thromboxane Res; 1980; 7():609-18. PubMed ID: 6989188
[No Abstract] [Full Text] [Related]
26. Tachyphylaxis of leukotriene C4-induced release of thromboxane A2 from guinea pig lung parenchyma and isoproterenol inhibition of this release.
Zijlstra FJ; Bonta IL; Vincent JE
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():167-71. PubMed ID: 6221589
[No Abstract] [Full Text] [Related]
27. Heparin potentiates synthesis of thromboxane A2 in human platelets.
Anderson WH; Mohammad SF; Chuang HY; Mason RG
Adv Prostaglandin Thromboxane Res; 1980; 6():287-91. PubMed ID: 7386269
[No Abstract] [Full Text] [Related]
28. Prevention of experimentally induced gastric damage with the tripeptide ZAMI-420, a new thromboxane synthesis inhibitor.
Gervasi GB; Fossati A; Caliari S; Rapalli L; Bergamaschi M
Int J Tissue React; 1983; 5(3):253-6. PubMed ID: 6418678
[TBL] [Abstract][Full Text] [Related]
29. Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists.
Swayne GT; Maguire J; Dolan J; Raval P; Dane G; Greener M; Owen DA
Eur J Pharmacol; 1988 Aug; 152(3):311-9. PubMed ID: 2975605
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the vascular responses to various prostanoic compounds in the puppy and adult dog.
Fitzpatrick T; Harris R; Ramwell P; Kot P
Adv Prostaglandin Thromboxane Res; 1980; 7():727-9. PubMed ID: 6989200
[No Abstract] [Full Text] [Related]
31. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
33. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
Whittle BJ; Kauffman GL; Moncada S
Nature; 1981 Jul; 292(5822):472-4. PubMed ID: 7195986
[No Abstract] [Full Text] [Related]
34. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
35. Prostacyclin and the vascular endothelium.
Moncada S; Vane JR
Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
[No Abstract] [Full Text] [Related]
36. Analysis of the biological activity of azoprostanoids in human platelets.
Gorman RR; Shebuski RJ; Aiken JW; Bundy GL
Fed Proc; 1981 May; 40(7):1997-2000. PubMed ID: 7014259
[TBL] [Abstract][Full Text] [Related]
37. Development of dual-acting benzofurans for thromboxane A2 receptor antagonist and prostacyclin receptor agonist: synthesis, structure-activity relationship, and evaluation of benzofuran derivatives.
Ohno M; Miyamoto M; Hoshi K; Takeda T; Yamada N; Ohtake A
J Med Chem; 2005 Aug; 48(16):5279-94. PubMed ID: 16078846
[TBL] [Abstract][Full Text] [Related]
38. Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction.
Raz A; Minkes MS; Needleman P
Biochim Biophys Acta; 1977 Aug; 488(2):305-11. PubMed ID: 560869
[No Abstract] [Full Text] [Related]
39. Quinone derivatives: synthesis and structure-activity relations of a novel class of eicosanoid antagonists, AA-2414 and its analogs.
Terao S
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():651-4. PubMed ID: 2526553
[No Abstract] [Full Text] [Related]
40. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
